Compass Therapeutics, Inc. · NASDAQ:CMPX
Blackstone Alternative Asset Management Associates LLC's stake in Compass Therapeutics, Inc. fell to 3.40% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Blackstone Alternative Asset Management Associates LLC's stake in Compass Therapeutics, Inc. fell to 3.40%, 6,126,182 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 3.40%
- Shares
- 6,126,182
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blackstone Annex Master Fund L.P. | 1.40% | 2,447,820 |
| Spruce Street Aggregator L.P. | 2.10% | 3,678,362 |
| Blackstone Alternative Asset Management Associates LLC | 3.40% | 6,126,182 |
| Blackstone Holdings II L.P. | 3.40% | 6,126,182 |
| Blackstone Holdings I/II GP L.L.C. | 3.40% | 6,126,182 |
| Blackstone Inc. | 3.40% | 6,126,182 |
| Blackstone Group Management L.L.C. | 3.40% | 6,126,182 |
| Stephen A. Schwarzman | 3.40% | 6,126,182 |
Source
Related
- Compass Therapeutics, Inc.
- Blackstone Holdings II L.P.
- Compass Therapeutics, Inc. shareholders
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026